News - PharmaLink, Merck KGaA

Filter

Current filters:

PharmaLinkMerck KGaA

Popular Filters

1 to 25 of 98 results

Merck Serono in deal with Auxogyn to advance fertility research

03-04-2014

USA-based Auxogyn, a company dedicated to advancing women’s reproductive health, has entered into an…

AuxogynLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

EMD Serono, Pfizer and Broad Institute link up on lupus research

EMD Serono, Pfizer and Broad Institute link up on lupus research

01-04-2014

EMD Serono, a US subsidiary of Germany’s Merck KGaA, has signed a research agreement with US pharma…

Anti-Arthritics/RheumaticsEMD SeronoMerck KGaAPfizerPharmaceuticalResearch

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

26-03-2014

German pharma and chemical major Merck KGaA has announced the promotion of three distinguished internal…

AllergopharmaBiotechnologyBoardroomGermanyMerck KGaAPharmaceutical

Germany’s Merck benefits from efficiency measures, with 2013 EBITDA up 9.7%

Germany’s Merck benefits from efficiency measures, with 2013 EBITDA up 9.7%

06-03-2014

German pharma and chemical major Merck KGaA this morning announced strong fourth-quarter and full-year…

FinancialMerck KGaAMerck SeronoPharmaceutical

Merck Serono’s Erbitux to be funded by CDF in England for mCRC

28-02-2014

The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit

20-02-2014

Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Merck KGaA names new board members

Merck KGaA names new board members

28-01-2014

E. Merck KG, which combines the financial interests of the Merck family and is general partner of Germany’s…

BoardroomGermanyMerck KGaAPharmaceutical

Merck KGaA’s CFO Matthias Zachert joins Lanxess as CEO

Merck KGaA’s CFO Matthias Zachert joins Lanxess as CEO

27-01-2014

Chief financial officer of Germany’s Merck KGaA (MRK: DE) Matthias Zachert has been appointed as chief…

BoardroomLanxessMerck KGaAPharmaceutical

European Commission backs wider use of Merck’s Erbitux

European Commission backs wider use of Merck’s Erbitux

24-12-2013

Merck Serono, the biopharmaceutical division of Germany’s Merck KGaA, has gained European Commission…

ErbituxEuropeMerck KGaAMerck SeronoOncologyPharmaceuticalRegulation

Merck Serono partners with Spanish research center for cancer drug development

Merck Serono partners with Spanish research center for cancer drug development

19-12-2013

Merck Serono, the biotech division of German life sciences group Merck KGaA, has signed an accord with…

BiotechnologyLicensingMerck KGaAMerck SeronoNorthern EuropeOncologyResearch

Merck’s Allergopharma to invest 40 million euros in production facility

Merck’s Allergopharma to invest 40 million euros in production facility

12-12-2013

Germany’s Merck KGaA has broken ground on a new production facility for its Allergopharma unit in Reinbek…

AllergopharmaFinancialImmunologicalsMerck KGaAPharmaceuticalProduction

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Germany’s Merck invests in further research partnerships in Israel

Germany’s Merck invests in further research partnerships in Israel

26-11-2013

German pharma and chemicals firm Merck KGaA says it is increasingly counting on partnerships with Israeli…

BiotechnologyChanBioFinancialMerck KGaAMetabomedNeurologicalOncologyResearchRest of the World

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

20-11-2013

Privately-held Biopharma GmbH says it has signed an agreement with Merck Serono, the biopharma subsidiary…

Anti-Arthritics/RheumaticsBiopharm GmbHMerck KGaAMerck SeronoPharmaceuticalResearch

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

20-11-2013

German privately-owned biopharmaceutical company Affimed Therapeutics has appointed Jens-Peter Marschner…

Affimed TherapeuticsBoardroomEuropeMerck KGaA

Merck KGaA to invest 80 million euros in China pharma production

Merck KGaA to invest 80 million euros in China pharma production

15-11-2013

Germany’s Merck KGaA said this morning that it plans to invest 80 million euros ($106.8 million) in…

Asia-PacificFinancialMerck KGaAMerck SeronoPharmaceuticalProduction

Merck KGaA improves guidance with strong third quarter results

Merck KGaA improves guidance with strong third quarter results

14-11-2013

Germany’s Merck KGaA (MRK: DE) has posted solid organic revenue growth of 4.7% for the third quarter…

BiotechnologyErbituxEuropeFinancialMerck KGaAMerck SeronoPharmaceuticalRebif

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

08-11-2013

The Brazilian Ministry of Health is managing a series of product development partnerships and the selection…

Anti-Arthritics/RheumaticsBionovisBiotechnologyFinancialMerck KGaAMerck SeronoOncologyProductionSouth America

Gerhard Schmitz to join Merck KGaA as new head of global accounting

Gerhard Schmitz to join Merck KGaA as new head of global accounting

30-10-2013

Merck KGaA announced today that Gerhard Schmitz will join the pharmaceutical, chemical and life science…

BoardroomEuropeMerck KGaAPharmaceutical

US orphan status for Pharmalink’s Busulipo

US orphan status for Pharmalink’s Busulipo

29-10-2013

Swedish specialty pharma group Pharmalink says its product Busulipo, (busulfan), a best-in-class conditioning…

BusulipoNefeconNephrology and HepatologyNorth AmericaOncologyPharmaceuticalPharmaLinkRegulationResearch

Merck Serono and Selvita collaborate on cancer research

Merck Serono and Selvita collaborate on cancer research

24-10-2013

Merck Serono and Poland-based biotech firm Selvita have entered into a collaboration to jointly discover…

BiotechnologyMerck KGaAMerck SeronoOncologyResearchSelvita

Highlights from European Cancer Congress on Kadcyla, Yervoy, Erbitux and Somatuline

30-09-2013

A host of new oncology data was presented at the European Cancer Congress in Amsterdam, the Netherlands,…

Bristol-Myers SquibbErbituxEuropeIpsenKadcylaMerck KGaAOncologyPharmaceuticalResearchRocheSomatulineYervoy

1 to 25 of 98 results

Back to top